Navigation Links
XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
Date:10/10/2008

vate Securities Litigation Reform Act of 1995. Statements in this press release regarding XTENT's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, these statements include, but are not limited to those concerning the timing of the release of its clinical trial data. Forward-looking statements are based on management's current, preliminary expectations, and are subject to risks and uncertainties that could cause actual results to differ from the results predicted and which are included in the "Risk Factors" section of XTENT's quarterly report on Form 10-Q for the quarter ended June 30, 2008. This quarterly report was filed with the SEC on August 12, 2008, and is available on the company's investor relations website at http://www.xtentinc.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. XTENT undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. XTENT Announces First Quarter 2008 Financial Results
5. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
6. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
7. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
8. XTENT Announces European Regulatory Update
9. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Neurotrope Bioscience, Inc., ... a world-wide, exclusive license agreement with the Icahn School ... ( Mount Sinai ) to utilize its ... Bryostatin-1 in the treatment of Niemann-Pick Type C Disease ... afflicted with Alzheimer-like symptoms. The license also covers other ...
(Date:7/22/2014)... , July 22, 2014 WuXi PharmaTech (Cayman) ... and medical device R&D outsourcing company with operations in ... , today announced that it will release financial results ... Stock Exchange closes on Wednesday, August 13, 2014 (which will ... release will be available on the investor relations section of ...
(Date:7/22/2014)... July 22, 2014  UL (Underwriters Laboratories), a ... U.S. Food and Drug Administration (FDA) has recognized ... for medical devices incorporating lithium or nickel-based batteries. ... for Household and Commercial Batteries, and UL 1642 ... Consensus standards are standards recognized by the ...
Breaking Medicine Technology:Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... 6, 2011 A new study , released ... the United States witnessed opiate prescriptions for chronic abdominal ... Michael Lowenstein, co-medical director for the Waismann Method, an ... that this increase signals the gaining popularity of prescription ...
...  Glowpoint, Inc. (OTCBB: GLOW), a leading global provider of ... a leading global pharmaceutical services company has signed with ...   This new Glowpoint customer is the ... clinical, commercial, consulting and capital solutions. The firm has ...
Cached Medicine Technology:Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 2Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 3Global Pharmaceutical Services Company Turns to Glowpoint's OpenVideo™ Cloud 2
(Date:7/22/2014)... heart disease, Dr. Ross Feldman says women are often in ... a men,s-only disease, however, data has shown that post-menopausal women ... and are less likely to be adequately diagnosed and treated. ... the British Journal of Clinical Pharmacology brings to ... helps to identify which women are more prone to heart ...
(Date:7/22/2014)... 2014 As reported on July 17, 2014 ... to name her favorite beauty products, “ Botox , that’s ... that “ Botox has changed my life” by halving ... preparing for her various, daily appearances. “Suddenly my eyelids ... (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s response to ...
(Date:7/22/2014)... Rochelle, NY -- New guidelines on cholesterol treatment and ... double the risk of dying from atherosclerotic cardiovascular disease ... do women with a similar risk profile (based on ... The implications of this finding for when and how ... Editorial in Journal of Men,s Health , a ...
(Date:7/22/2014)... DC (PRWEB) July 22, 2014 Ticket Down ... Inter Milan tickets at Fedex Field in Landover, MD. ... to be a fan of international soccer. After the success of ... Brazil, soccer fever is alive and well. One way that fans ... for the sport is with the 2014 Guinness International Champions Cup. ...
(Date:7/22/2014)... July 22, 2014 The park is ... the Kendalltown Homeowners Association, Inc., made a ... residential community with the purchase of playground equipment from ... located in beautiful Miami Florida, and is a 475-unit ... of the surrounding landscape has created a tropical paradise ...
Breaking Medicine News(10 mins):Health News:Gene variant identified as a heart disease risk factor for women 2Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3
... proud to now serve as a presenting sponsor for the ... celebrates and supports the efforts to overcome cancer.ATLANTA, April 17 ... the science of cancer care, it,s easy to lose sight ... of the journey.Motivated by the Relay for Life events of ...
... As little as 10 minutes of exposure changes cardiovascular ... -- Cardiovascular function can be affected by as little ... other air pollutants such as wood smoke and smoke ... increasing evidence that higher levels of air pollution are ...
... study involves effort to improve chemotherapy effectiveness , , FRIDAY, April ... and testing, only a small percentage of cancer agents make ... come up with a way to weed out the duds ... marketplace. , The new model, a so-called "phase 0" ...
... April 17 In recognition of the 20th anniversary of ... global hemophilia community by pledging euro 250,000 to the World ... around the world will engage in activities to support the ... and promote support for the needs of people living with ...
... Ninety Percent of People Being Treated for Bipolar Disorder ... Depressive Symptoms (1)WASHINGTON, April 17 A ... living with bipolar disorder and 500 physicians who treat ... among people living with bipolar disorder (73%) is that ...
... making it possible to view the likely outcome of breast augmentation ... with McCormack Plastic Surgery is taking advantage of it. , ... ... asked by women considering breast surgery is typically: ‘What will I ...
Cached Medicine News:Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 2Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 3Health News:Secondhand Smoke Quickly Affects Blood Vessels 2Health News:'Phase 0' Trials Aim to Speed Cancer Drug Development 2Health News:'Phase 0' Trials Aim to Speed Cancer Drug Development 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 2Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 4Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 5Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 2Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 3Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 4Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 5Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 2Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 3
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
Inquire...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: